NCT06786078Recruiting
The Lily Device Trial
PREVAIL: a Clinical Investigation on Providing Reduced Effects of Visible Alopecia Caused by Chemotherapy Using the Lily Device - a Safety and Efficacy Study.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Luminate Medical, Inc.
- Participants (registry)
- 85
- Start
- December 2024
- Primary completion
- July 2025
- Study completion
- November 2025
- Last registry update
- January 2025
- Countries
- United States
Conditions studied: Chemotherapy Induced Alopecia
Interventions: Lily Device
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.